Showing results (211-220 of 321) with videos related to

Sort By:
Pageof 33
International Journal of Radiation Oncology, Biology, Physics|May 15, 1994
Pharmacokinetics, metabolism and distribution of 1,2-dihydro-8-(4-methylpiperazinyl)-4-phenylimidazo [1,2-A] pyrido [3,2-E] pyrazine-5-oxide in C3H miceB M Sutton, N J Reeves, M A Naylor, et al.
Journal of Medicinal Chemistry|August 24, 2011
Novel inhibitors of NRH:quinone oxidoreductase 2 (NQO2): crystal structures, biochemical activity, and intracellular effects of imidazoacridin-6-onesMark S Dunstan, John Barnes, Matthew Humphries, et al.
The British Journal of Radiology|July 28, 2005
An assessment of clinically optimal gold marker length and diameter for pelvic radiotherapy verification using an amorphous silicon flat panel electronic portal imaging deviceA M Henry, J Stratford, J Davies, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|November 21, 2012
Inhibition of carbonic anhydrase activity modifies the toxicity of doxorubicin and melphalan in tumour cells in vitroRoben G Gieling, Catriona A Parker, Lisa A De Costa, et al.
British Journal of Cancer|November 1, 1991
In vivo 31P nuclear magnetic resonance spectroscopy of experimental murine tumours and human tumour xenografts: effects of blood flow modificationJ C Bremner, C J Counsell, G E Adams, et al.
British Journal of Cancer|March 29, 2000
Pretreatment apoptosis in carcinoma of the cervix correlates with changes in tumour oxygenation during radiotherapyM T Sheridan, C M West, R A Cooper, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1996
A comparison of the physiological effects of RSU1069 and RB6145 in the SCCVII murine tumourP J Wood, M R Horsman, A A Khalil, et al.
Nature Medicine|May 1, 1997
Targeting gene expression to hypoxic tumor cellsG U Dachs, A V Patterson, J D Firth, et al.
International Journal of Radiation Oncology, Biology, Physics|May 15, 1994
The role of DT-diaphorase in determining the sensitivity of human tumor cells to tirapazamine (SR 4233)A V Patterson, N Robertson, S Houlbrook, et al.
Drug Design and Discovery|January 1, 1993
Synthesis of the enantiomers of the bioreductively-activated cytotoxin RSU-1069 and its prodrug RB6145 and lack of stereoselectivity in their cytotoxicity and radiosensitization in vitroM A Naylor, M D Threadgill, H D Showalter, et al.
Pageof 33